Inter Pharma (Thailand) Performance
| IP Stock | THB 3.14 0.04 1.26% |
The company retains a Market Volatility (i.e., Beta) of 0.14, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Inter Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Inter Pharma is expected to be smaller as well. At this point, Inter Pharma Public has a negative expected return of -0.52%. Please make sure to check out Inter Pharma's daily balance of power, and the relationship between the skewness and day typical price , to decide if Inter Pharma Public performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Inter Pharma Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental drivers remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
| Begin Period Cash Flow | 152.3 M | |
| Total Cashflows From Investing Activities | -351.8 M | |
| Free Cash Flow | -279.4 M |
Inter |
Inter Pharma Relative Risk vs. Return Landscape
If you would invest 436.00 in Inter Pharma Public on October 6, 2024 and sell it today you would lose (122.00) from holding Inter Pharma Public or give up 27.98% of portfolio value over 90 days. Inter Pharma Public is currently producing negative expected returns and takes up 2.1076% volatility of returns over 90 trading days. Put another way, 18% of traded stocks are less volatile than Inter, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Inter Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inter Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inter Pharma Public, and traders can use it to determine the average amount a Inter Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2483
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IP |
Estimated Market Risk
| 2.11 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.25 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inter Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inter Pharma by adding Inter Pharma to a well-diversified portfolio.
Inter Pharma Fundamentals Growth
Inter Stock prices reflect investors' perceptions of the future prospects and financial health of Inter Pharma, and Inter Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inter Stock performance.
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0524 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 4.5 B | |||
| Shares Outstanding | 372.52 M | |||
| Price To Earning | 115.05 X | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 3.66 X | |||
| Revenue | 908.63 M | |||
| EBITDA | 172.3 M | |||
| Cash And Equivalents | 153.09 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 187.06 M | |||
| Debt To Equity | 0.25 % | |||
| Book Value Per Share | 5.09 X | |||
| Cash Flow From Operations | (41.57 M) | |||
| Earnings Per Share | 0.43 X | |||
| Total Asset | 1.33 B | |||
About Inter Pharma Performance
By examining Inter Pharma's fundamental ratios, stakeholders can obtain critical insights into Inter Pharma's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Inter Pharma is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. The company was founded in 2006 and is headquartered in Bangkok, Thailand. INTER PHARMA is traded on Stock Exchange of Thailand in Thailand.Things to note about Inter Pharma Public performance evaluation
Checking the ongoing alerts about Inter Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inter Pharma Public help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inter Pharma Public generated a negative expected return over the last 90 days | |
| Inter Pharma Public has accumulated about 153.09 M in cash with (41.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53. | |
| Roughly 47.0% of the company shares are held by company insiders |
- Analyzing Inter Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inter Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Inter Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inter Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inter Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inter Pharma's stock. These opinions can provide insight into Inter Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Inter Stock
Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.